Clinical Trial Update: Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating memantine for autism spectrum disorder in adolescents has completed, with results posted describing behavioral and neural responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Autism Spectrum Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-09-11